Biomolecular Life Holdings, Inc. SEC filings BIOM

Biomolecular Life Holdings, Inc. has 211 filings in SEC EDGAR's recent list, going back to Jul 29, 1999. Its latest annual report, Form 10-K, was filed on Apr 15, 2015 for the period ended Dec 31, 2014. The latest quarterly report (Form 10-Q) was filed on Nov 19, 2015, covering the quarter ended Sep 30, 2015. The most recent current report (Form 8-K) was filed on Mar 30, 2016 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
424B3 Prospectus Feb 12, 2015 —
S-1/A Amended registration statement Feb 11, 2015 —
S-1 Registration statement Feb 6, 2015 —
S-1/A Amended registration statement Jan 20, 2015 —
S-1 Registration statement Nov 25, 2014 —
S-8 Employee stock plan registration Jul 16, 2007 —
424B3 Prospectus Mar 8, 2007 —
424B3 Prospectus Jan 3, 2007 —
424B3 Prospectus Dec 1, 2006 —
424B3 Prospectus Nov 1, 2006 —
424B3 Prospectus Oct 4, 2006 —
424B3 Prospectus Aug 31, 2006 —
424B3 Prospectus Aug 7, 2006 —

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BIOM (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Miami, FL
SEC filer status
Smaller reporting company
SEC CIK
1091326
Former names
SB Technology Holdings, Inc. (until May 4, 2026); VG Life Sciences Inc. (until Mar 6, 2026); VG Life Sciences, Inc. (until Oct 14, 2014); VIRAL GENETICS INC /DE/ (until Mar 25, 2009); 5 STARLIVING ONLINE INC (until Oct 18, 2001)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.